Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

40.18 +0.17 (+0.42%)
Official Closing Price Updated: 7:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Capturing the U.S. Health Care Space with XLV
Via Get News
Topics ETFs
Exposures COVID-19
When Does Pfizer Become A Bargain?
With a price-to-earnings ratio of less than 9 and a dividend yield of 3.63% you have to be thinking that Pfizer may a bit of a bargain down here. 
Via MarketBeat
Exposures COVID-19
3 Stocks to Buy With a Forward P/E of Less Than 10
These three undervalued stocks to buy trade at incredibly low price-earnings multiples, while also offering attractive dividend yields. 
Via InvestorPlace
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19. 
Via Benzinga
Tumor Lysis Syndrome Market Projected to Show Strong Growth : AbbVie, Hikma Pharmaceuticals, Amgen, Genentech
Get an extensive Tumor Lysis Syndrome Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
Pfizer: Dividend Insights
 
Via Benzinga
Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
COVID, Shmovid: This Could Be the Next Big Growth Story for Moderna Stock
Moderna could follow closely behind Pfizer and GSK in entering the lucrative RSV vaccine market. 
Via The Motley Fool
Stock Market Rally Pulls Back; Microsoft, Google Slash Jobs; Netflix, Goldman, Tesla In Focus: Weekly Review
Microsoft and Google are slashing jobs. Netflix and Tesla jumped. 
Via Investor's Business Daily
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
Here's a round-up of stories from around the globe and from various media outlets. Benzinga 
Via Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
The healthcare industry isn't going anywhere. 
Via The Motley Fool
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX). 
Via Benzinga
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
After years of lab failures, the companies could crack open a multibillion-dollar market. 
Via Investor's Business Daily
The 7 Best Dividend Stocks to Buy to Beat the Market
These are the best dividend stocks to buy to beat the market. They trade at undervalued levels and offer robust yields. 
Via InvestorPlace
Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide
Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023.  
Via Benzinga
Moderna and Pfizer Race to Release RSV Vaccines
Two of the largest vaccine producers have engaged in the rapid development of RSV vaccines, here's how the companies are tracking so far. 
Via MarketBeat
Exposures Product Safety
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
7 Biotech Stocks That Will Make You Rich in 10 Years
Although the health innovation space is risky, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years. 
Via InvestorPlace
Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market. 
Via SBWire
Health and Beauty Products Market to Eyewitness Massive Growth by 2028 : Wallgreen, Coty, Nestle
Stay up-to-date with Health and Beauty Products Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Jim Cramer Says This Stock Up 23% In A Month Is 'A Great Speculative Buy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Biohaven Ltd (NYSE: BHVN) is a "great speculative buy." 
Via Benzinga
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today
Moderna, Inc. (NASDAQ: MRNA) shares were solidly higher in premarket trading on Wednesday. 
Via Benzinga
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Moderna Comes Swinging For Pfizer, GSK As RSV Vaccine Battle Heats Up
Moderna is stepping up to Pfizer and GSK, both of which are developing RSV vaccines. 
Via Investor's Business Daily
The War Room/DailyClout Pfizer Documents Analysis Volunteers Publish e-Book Available on DailyClout.io's Website
The War Room/DailyClout team of 3,500 medical experts helped rip the veneer off the myth that mRNA injections are 
Via Newsworthy
Topics Death
Exposures COVID-19 Death Product Safety
Pfizer (PFE) Stock Falls on Analyst Downgrade
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock. 
Via InvestorPlace
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares
Shares have skidded almost 10% in the first two weeks of 2023. 
Via Investor's Business Daily
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
 
Via Benzinga
Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
From Pfizer Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.